- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Health Care Facilities/Srvcs
- Sub-Industry: Health Care Services
NeoStem Inc+ Add to Watchlist
NBS:US6.3500 USD 0.1700 2.75%
As of 20:10:00 ET on 12/06/2013.
Company Profile for NeoStem Inc (NBS)
NeoStem, Inc. develops and manufactures cell therapies. The Company through its subsidiaries offers contract manufacturing services and is developing a cell therapy for the treatment of cardiovascular disease.
Key Executives for NeoStem Inc (NBS)
|Robin L SmithChairman/CEO||Andrew L PecoraChief Visionary Officer|
|Douglas W LosordoChief Medical Officer||Stephen W PotterExec Vice President|
|Robert Dickey IVVP/CFO||Joseph Talamo "Joe"VP/Chief Acctg Officer|
|Catherine M VaczyVP/Secretary/General Counsel||Jonathan Sackner-BernsteinVP:Clinical Development|
|Larry A MayVP:Strategic Transactions|